Haydale Share News (HAYD)

Haydale Graphene Inks Deals With Swansea, Alex Thomson Racing

Haydale Graphene To Buy Development Partner EPL For GBP1.4 Million

Haydale Graphene Orders More Plasma Reactors From Tantec

Haydale Graphene Expects Revenue Increase In Coming Year

Haydale Graphene In Marketing Agreement For Asia-Pacific

Haydale Graphene Industries Signs Marketing, Distribution Deal

Haydale Graphene Enters New Consulting Agreement

Haydale Graphen to collaborate with WCPC

Technology group Haydale Graphene has partnered with WCPC to produce graphene-based inks in an effort to strengthen its product portfolio. WCPC, an R&D centre for printing and coating processes, is expected to develop and refine commercial ink formulations supplied by Haydale. The Swansea Univers

Haydale Graphene Inks Research Agreement With Swansea University

Jupiter finance chief reduces stake amid controversy at AGM

Jupiter Fund Management's Chief Financial Officer, Philip Johnson, traded in 63,588 shares, making only a small dent in his holding, which was reduced to 1.32m. Johnson, who took up the role in 2009, paid 383.80p per share, giving the deal a trade value of £244,051. The purchase was made the day

UK WINNERS & LOSERS: Standard Chartered, Barclays Lead FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 - WINNERS
-------
Barclays, up 4.9%. Barclays has detailed plans to shrink its investment bank with a new round

Hume Capital Plummets As Board Reviews Financial Resources, CEO Departs

LONDON (Alliance News) - Hume Capital Securities PLC plummeted to the bottom of the AIM All-Share market Thursday after the firm announced the resignation of Chief Executive Nitin Parekh amid a board review of its financial resources. The firm said it has appointed Jonathan Freeman, a non-e

Haydale Graphene: Not Planning Legal Action Against Hume Capital

LONDON (Alliance News) - Haydale Graphene Industries PLC Tuesday said its directors have "no current intention" of pursuing any legal action against its broker, Hume Capital Securities PLC. Haydale moved to distance itself from press reports suggesting it was gearing up to take the legal ro

UK MIDDAY BRIEFING: Drug Stocks Soar, Led By Glaxo And AstraZeneca

LONDON (Alliance News) - Pharmaceutical stocks are reigning over the first session following the long Easter bank holiday, with mergers and acquisitions leading investor interest.

GlaxoSmithKline has signed a three-part inter-conditional transaction with Swiss healt

UK WINNERS & LOSERS: Pharmaceutical Companies Jump On M&A News

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday.
-------
FTSE 100 - WINNERS
-------
AstraZeneca, up 7.1%. The pharmaceutical company has jumped after The Sunday